Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future
Liver transplantation (LT) is a highly effective treatment for carefully selected patients with
hepatocellular carcinoma (HCC). In this review, we explored the development of LT …
hepatocellular carcinoma (HCC). In this review, we explored the development of LT …
Normal CEA levels after neoadjuvant chemotherapy and cytoreduction with hyperthermic intraperitoneal chemoperfusion predict improved survival from colorectal …
MM Wach, G Nunns, A Hamed, J Derby… - Annals of Surgical …, 2024 - Springer
Background Normal carcinoembryonic antigen (CEA) levels (≤ 2.5 ng/ml) after resection of
localized colorectal cancer or liver metastases are associated with improved survival …
localized colorectal cancer or liver metastases are associated with improved survival …
Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase …
K Uemura, N Kondo, T Sudo… - Journal of Hepato …, 2024 - Wiley Online Library
Abstract Background/Purpose This study reports the long‐term results of a phase II trial
evaluating the clinical efficacy of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in …
evaluating the clinical efficacy of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in …
Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery
Y Ando, M Dbouk, AL Blackford, T Yoshida… - Annals of surgical …, 2024 - Springer
Abstract Background Cancer antigen 19-9 (CA19-9) is widely used as a marker of
pancreatic cancer tumor burden and response to therapy. Synthesis of CA19-9 and its …
pancreatic cancer tumor burden and response to therapy. Synthesis of CA19-9 and its …
Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma
KTD Yeung, J Doyle, S Kumar, K Aitken, D Tait… - Cancers, 2024 - mdpi.com
Simple Summary Patients diagnosed with advanced pancreatic cancer are commonly
treated with pre-operative chemotherapy and/or chemoradiotherapy. The aim of this study is …
treated with pre-operative chemotherapy and/or chemoradiotherapy. The aim of this study is …